Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1033-1034 (10 May), doi:10.1136/bmj.39563.620266.80
| The first 150 words of the full text of this article appear below. |
I thought we had laid to rest the myth that hormone replacement therapy (HRT) has a beneficial effect on cardiovascular disease. The American womens health initiative study, published in 2002,1 which was stopped short because combined HRT increased the risk of breast cancer 2.5-fold, also showed that HRT actually increased stroke and venous thrombosis by 29%.
The same study showed an increase in bone mineral density and reduction in fractures. Short course HRT has been shown to confer long term benefit,2 so the short course is the only sensible recommendation. It should be given only for severe menopausal side effects, because the risk of breast cancer increases with the duration of treatment.3
If we add in the higher risk of recall for further investigation after breast cancer screening and cervical screening shown by the million women study, with all the psychological distress that it causes, then it seems irresponsible for
Mark D Lewars, consultant radiologist
1 Southend Breast Unit, Southend University Hospital NHS Trust, Essex SS0 0RY
mark.lewars@southend.nhs.uk
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.